Ziprasidone population pharmacokinetics and co‑medication effects in Chinese patients Publication Ziprasidone population pharmacokinetics and co‑medication effects in Chinese patients Learn how lorazepam and valproate significantly affect ziprasidone clearance; PopPK modelling supports personalized dosing using…CertaraJune 25, 2024
Population pharmacokinetics of fluconazole for prevention or treatment of invasive candidiasis in Chinese young infants. Publication Population pharmacokinetics of fluconazole for prevention or treatment of invasive candidiasis in Chinese young infants. Find out how gestational and postnatal age drive fluconazole PK variability; PopPK modelling supports tailored…CertaraJune 8, 2024
Streamlining Biotech Data Compliance and Management with Certara’s Phoenix® Cloud Case Study Streamlining Biotech Data Compliance and Management with Certara’s Phoenix® Cloud Discover how Certara's Phoenix Hosted streamlined data compliance and management for a biotech company, enhancing…CertaraMay 31, 2024
Phoenix UGM 2024: A day of innovation and collaboration Blog Phoenix UGM 2024: A day of innovation and collaboration The Phoenix UGM featured industry expert insights, peer networking, and glimpses into the latest PK/PD…CertaraMay 31, 2024
Comparative Bioequivalence and Food Effect of Two Formulations of 30-mg Nifedipine Controlled-Release Tablets in Healthy Chinese Adults Publication Comparative Bioequivalence and Food Effect of Two Formulations of 30-mg Nifedipine Controlled-Release Tablets in Healthy Chinese Adults Explore how nifedipine CR formulations are bioequivalent; food reduces exposure modestly, analysed using Phoenix WinNonlin.CertaraMarch 13, 2024
Population pharmacokinetic model for oral ORIN1001 in Chinese patients with advanced solid tumors Publication Population pharmacokinetic model for oral ORIN1001 in Chinese patients with advanced solid tumors Discover how PopPK modelling supports dose‑adjustment considerations for ORIN1001 based on bilirubin and lean body…CertaraMarch 4, 2024
What is new in Phoenix 8.5? On-Demand Webinar What is new in Phoenix 8.5? Discover the latest advancements and enhancements in Phoenix version 8.5. Watch the webinar to learn…CertaraFebruary 26, 2024
Pharmacokinetic – toxicodynamic Modeling to Elucidate the Involvement of Dorsal Root Ganglion Neuron in Oxaliplatin – induced Peripheral Neurpathu Publication Pharmacokinetic – toxicodynamic Modeling to Elucidate the Involvement of Dorsal Root Ganglion Neuron in Oxaliplatin – induced Peripheral Neurpathu See how DRG‑based PK‑TD modelling predicts neuropathy severity and supports safer oxaliplatin dosing strategies using…CertaraFebruary 1, 2024
Comparative simulation of intraperitoneal aminoglycoside regimens for patients with peritonitis on automated peritoneal dialysis Publication Comparative simulation of intraperitoneal aminoglycoside regimens for patients with peritonitis on automated peritoneal dialysis Learn how both regimens achieve PK/PD targets; fixed‑dose regimen recommended with trough monitoring, modelled using…CertaraJanuary 30, 2024
The in vivo study on antioxidant activity of wendan decoction in treating hyperlipidemia: a pharmacokinetic-pharmacodynamic (PK-PD) model Publication The in vivo study on antioxidant activity of wendan decoction in treating hyperlipidemia: a pharmacokinetic-pharmacodynamic (PK-PD) model Find out how PK‑PD modelling shows delayed lipid‑lowering effects driven by key flavonoids in Wendan…CertaraJanuary 23, 2024